Variable | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
P value | Odds ratio | 95% CI | P value | Odds ratio | 95% CI | |
Demographics | ||||||
Male, n (%) | 0.10 | 5.29 | 0.69–40.32 |  |  |  |
Age at onset, years | 0.64 | 0.93 | 0.94–1.04 |  |  |  |
Number of involved organs (≥ 5) | 0.04 | 3.02 | 1.07–8.53 |  |  |  |
Lacrimal gland | 0.14 | 1.54 | 0.86–2.73 |  |  |  |
Parotid | 0.91 | 1.03 | 0.60–1.76 |  |  |  |
Submandibular gland | 0.79 | 0.93 | 0.56–1.56 |  |  |  |
Lung | 0.18 | 0.50 | 0.18–1.38 |  |  |  |
Retroperitoneal fibrosis | 0.37 | 1.34 | 0.71–2.52 |  |  |  |
Pancreas | 0.07 | 4.02 | 0.90–17.87 |  |  |  |
Bile duct | 0.07 | 1.65 | 0.96–2.85 |  |  |  |
Lymph node | 0.34 | 0.78 | 0.46–1.30 |  |  |  |
Kidney | 0.34 | 1.67 | 0.58–4.83 |  |  |  |
IgG4, median (IQR), g/l | 0.08 | 1.03 | 1.00–1.06 | 0.65 | 1.01 | 0.97–1.05 |
Serum IgG4 level ≥ 5 ULN | 0.15 | 2.50 | 0.70–8.88 |  |  |  |
IgG4-RD RI scores | 0.04 | 1.06 | 1.00–1.12 | 0.69 | 0.98 | 0.91–1.07 |
Score of ACR/EULAR IgG4-RD Classification Criteria | 0.004 | 1.07 | 1.02–1.11 | 0.02 | 1.10 | 1.02–1.19 |
Score of ACR/EULAR IgG4-RD Classification Criteria ≥ 20 | 0.55 | 0.54 | 0.07–4.08 |  |  |  |
GC + IM therapy n (%) | 0.04 | 0.12 | 0.02–0.93 | 0.06 | 0.14 | 0.02–1.06 |
Complete GC withdrawal | 0.02 | 3.35 | 1.21–9.29 | 0.01 | 4.07 | 1.33–12.51 |